Scientist III
Thermo Fisher
Ning Xu, MD, PhD, Scientist III at Thermo Fisher Scientific, leads the development of CXCL10 urinary biomarker tests in the Transplant Diagnostics division. With over 15 years of experience in biotech and pharma, she excels in biomarker and antibody detection discovery, assay development and validation, accuracy and precision enhancement, and cross-functional collaboration. Her expertise drives the creation of innovative diagnostic solutions for patients and clinicians in pre- and post-transplant medicine.